Considerations on occupational medical surveillance in employees handling nanoparticles

  • Michael Nasterlack
  • Andreas Zober
  • Christoph Oberlinner
Original Article

Abstract

Objectives

The use of engineered nanoparticles not only offers new technical perspectives but also raises questions regarding possible health aspects for producers and users. Nanoparticles may, just by virtue of their size, exert biological effects unrelated to the chemicals they are composed of. These considerations, and results from experimental animal studies suggesting that engineered nanomaterials may pose a health hazard to employees, all underscore the need for preventive measures. In this context, the need for, the feasibility, and the appropriateness of targeted occupational medical surveillance are currently subject to debate.

Methods

We compared established concepts for the development of occupational medical surveillance programs to existing knowledge on exposures in workplaces and on health effects of nanomaterials.

Results

A variety of potential effect parameters have been proposed for medical surveillance of exposed personnel, such as heart rate variability, blood-clotting parameters, pro-inflammatory cytokines, etc. None of these parameters are specific, most are not validated as individual health risk indicators, and some require sophisticated equipment not routinely available. Against this background, BASF currently puts specific weight on risk assessment and exposure control in workplaces. Particle emissions are primarily avoided by manufacturing in closed systems or using effective extraction systems. Appropriate personal protective equipment has been defined for such operations where an exposure potential cannot be excluded.

Conclusions

While there is presently no evidence-based foundation for “nano-specific” occupational medical screening, one can perform general medical screening with methods targeted at some of the health outcomes under discussion. The results of such examinations can provide a basis for future epidemiologic studies. Therefore, the establishment of exposure registries to enable the conduct of large-scale multi-centric prospective epidemiologic studies is recommended.

Keywords

Nanoparticles Occupational medical surveillance Risk assessment 

References

  1. Aitken RJ, Chaudhry MQ, Boxall ABA, Hull M (2006) Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med 56:300–306CrossRefGoogle Scholar
  2. Antonini JM (2003) Health effects of welding. Crit Rev Toxicol 33:61–103PubMedCrossRefGoogle Scholar
  3. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127:1701–1712PubMedGoogle Scholar
  4. BASF (2004) Guide to safe manufacture and for activities involving nanoparticles in the workplace. http://corporate.basf.com/en/sustainability/dialog/nanotechnologie/mitarbeiter.htm?id=dipTAAfbhbcp-lj. Last accessed 26 June 2007
  5. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang LS, Cox C, Zareba W, Oberdörster G (2005) Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 171:1129–1135PubMedCrossRefGoogle Scholar
  6. Blättler MA (1998) Schadstoffexposition beim Schweißen. Sichere Arbeit, pp 25–29Google Scholar
  7. Borak J, Woolf SH, Fields CA (2006) Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment. J Occup Environ Med 48:937–947PubMedCrossRefGoogle Scholar
  8. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J., Warheit D, Oberdörster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3. doi:10.1186/1743-8977-3-11
  9. Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P (2007) Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 20:148–154PubMedCrossRefGoogle Scholar
  10. Gamer AO, Leibold E, van Ravenzwaay B (2006) The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 20:301–307PubMedCrossRefGoogle Scholar
  11. Garnett MC, Kallinteri P (2006) Nanomedicines and nanotoxicology: some physiological principles. Occup Med 56:307–311CrossRefGoogle Scholar
  12. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI (2007) Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 115:403–409PubMedGoogle Scholar
  13. Gwinn MR, Vallyathan V (2007) Nanoparticles: health effects—pros and cons. Environ Health Perspect 115:1818–1825Google Scholar
  14. IARC (1990) Chromium, nickel and welding. In: WHO (ed) IARC monographs on the evaluation of carcinogenic risks to humans, Geneva, vol 49, pp 447–525Google Scholar
  15. Konietzko N, Jung H, Hering KG, Schmidt T (2001) Das Strahlenrisiko bei Röntgenuntersuchungen des Thorax. Pneumologie 55:57–71PubMedCrossRefGoogle Scholar
  16. Kuhlbusch TA, Fissan H (2006) Particle characteristics in the reactor and pelletizing areas of carbon black production. J Occup Environ Hyg 3:558–567PubMedCrossRefGoogle Scholar
  17. Maynard A, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit D (2006) Safe handling of nanotechnology. Nature 444:267–269PubMedCrossRefGoogle Scholar
  18. NIOSH, National Institute for Occupational Safety and Health (2007) Progress toward safe nanotechnology in the workplace. DHHS (NIOSH) Publication No. 2007-123Google Scholar
  19. Oberdörster G (2001) Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 74:1–8PubMedCrossRefGoogle Scholar
  20. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology—an emerging discipline involving studies of ultrafine particles. Environ Health Perspect 113:823–839PubMedCrossRefGoogle Scholar
  21. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445PubMedCrossRefGoogle Scholar
  22. Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro-Riviere NA (2007) Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 7:155–160PubMedCrossRefGoogle Scholar
  23. Scharrer E, Hessel H, Kronseder A, Guth W, Rolinski B, Jörres RA, Radon K, Schierl R, Angerer P, Nowak D (2007) Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume. Int Arch Occup Environ Health 80:265–272PubMedCrossRefGoogle Scholar
  24. Schulte PA, Salamanca-Buentello F (2007) Ethical and scientific issues of nanotechnology in the workplace. Environ Health Perspect 115:5–12PubMedGoogle Scholar
  25. Seaton A (2006) Nanotechnology and the occupational physician. Occup Med 56:312–316CrossRefGoogle Scholar
  26. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, Autran B, Sterry W, Blume-Peytavi U (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316–1322PubMedCrossRefGoogle Scholar
  27. Warheit DB, Borm PJ, Hennes C, Lademann J (2007) Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol 19:631–643PubMedCrossRefGoogle Scholar
  28. Wieners D, Latza U, Baur X (2000) Inhalative Belastungen durch Schweißverfahren. Zbl Arbeitsmed 50:38–44Google Scholar
  29. Wittmaack K (2007) In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what? Environ Health Perspect 115:187–194PubMedGoogle Scholar
  30. Wörle-Knirsch JM, Pulskamp K, Krug HF (2006) Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261–1268PubMedCrossRefGoogle Scholar
  31. Yeatts K, Svendsen E, Creason J, Alexis N, Herbst M, Scott J, Kupper L, Williams R, Neas L, Cascio W, Devlin RB, Peden DB (2007) Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma. Environ Health Perspect 115:709–714PubMedCrossRefGoogle Scholar
  32. Zober A (1981) Symptoms and findings at the bronchopulmonary system of electric arc welders. Zbl Bakt Hyg 173:92–119Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Michael Nasterlack
    • 1
  • Andreas Zober
    • 1
  • Christoph Oberlinner
    • 1
  1. 1.Occupational Medicine and Health Protection DepartmentLudwigshafenGermany

Personalised recommendations